nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—EDNRA—coronary artery disease	0.461	1	CbGaD
Sulfisoxazole—EDNRA—Acetylsalicylic acid—coronary artery disease	0.261	0.578	CbGbCtD
Sulfisoxazole—CYP2C9—Fenofibrate—coronary artery disease	0.0292	0.0648	CbGbCtD
Sulfisoxazole—CYP2C9—Gemfibrozil—coronary artery disease	0.0234	0.0518	CbGbCtD
Sulfisoxazole—CYP2C9—Clopidogrel—coronary artery disease	0.0202	0.0449	CbGbCtD
Sulfisoxazole—CYP2C9—Pitavastatin—coronary artery disease	0.0177	0.0392	CbGbCtD
Sulfisoxazole—CYP2C9—Valsartan—coronary artery disease	0.0172	0.0382	CbGbCtD
Sulfisoxazole—CYP2C9—Rosuvastatin—coronary artery disease	0.013	0.0289	CbGbCtD
Sulfisoxazole—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0127	0.0282	CbGbCtD
Sulfisoxazole—CYP2C9—Simvastatin—coronary artery disease	0.0121	0.0269	CbGbCtD
Sulfisoxazole—CYP2C9—Lovastatin—coronary artery disease	0.0119	0.0263	CbGbCtD
Sulfisoxazole—CYP2C9—Pravastatin—coronary artery disease	0.0119	0.0263	CbGbCtD
Sulfisoxazole—CYP2C9—Atorvastatin—coronary artery disease	0.0108	0.024	CbGbCtD
Sulfisoxazole—CYP2C9—Losartan—coronary artery disease	0.00989	0.0219	CbGbCtD
Sulfisoxazole—CYP2C9—cardial valve—coronary artery disease	0.00932	0.512	CbGeAlD
Sulfisoxazole—EDNRA—cardiac ventricle—coronary artery disease	0.00237	0.13	CbGeAlD
Sulfisoxazole—EDNRA—myocardium—coronary artery disease	0.00223	0.123	CbGeAlD
Sulfisoxazole—EDNRA—heart—coronary artery disease	0.00156	0.0855	CbGeAlD
Sulfisoxazole—EDNRA—cardiac atrium—coronary artery disease	0.00133	0.0732	CbGeAlD
Sulfisoxazole—CYP2C9—heart—coronary artery disease	0.000515	0.0283	CbGeAlD
Sulfisoxazole—CYP2C9—cardiovascular system—coronary artery disease	0.000486	0.0267	CbGeAlD
Sulfisoxazole—CYP2C9—blood—coronary artery disease	0.000384	0.0211	CbGeAlD
Sulfisoxazole—Sulfamethazine—ALB—coronary artery disease	0.000153	0.172	CrCbGaD
Sulfisoxazole—Dapsone—MPO—coronary artery disease	0.000152	0.172	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—coronary artery disease	0.000149	0.168	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—coronary artery disease	0.000116	0.131	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2C19—coronary artery disease	0.000103	0.116	CrCbGaD
Sulfisoxazole—Dapsone—CYP2C19—coronary artery disease	9.17e-05	0.103	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—ALB—coronary artery disease	6.5e-05	0.0733	CrCbGaD
Sulfisoxazole—Dapsone—PTGS2—coronary artery disease	5.71e-05	0.0644	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGT—coronary artery disease	2.8e-05	0.000409	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP2CA—coronary artery disease	2.79e-05	0.000407	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL3—coronary artery disease	2.78e-05	0.000405	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL2—coronary artery disease	2.78e-05	0.000405	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	2.76e-05	0.000403	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SDC1—coronary artery disease	2.75e-05	0.000401	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2R—coronary artery disease	2.75e-05	0.000401	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCD—coronary artery disease	2.74e-05	0.0004	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—coronary artery disease	2.69e-05	0.000393	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGB—coronary artery disease	2.69e-05	0.000392	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—coronary artery disease	2.68e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—C3—coronary artery disease	2.68e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDNRB—coronary artery disease	2.66e-05	0.000388	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—coronary artery disease	2.66e-05	0.000387	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	2.65e-05	0.000386	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—THBS1—coronary artery disease	2.62e-05	0.000382	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	2.6e-05	0.000379	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	2.6e-05	0.000379	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSMA6—coronary artery disease	2.6e-05	0.000379	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSMB5—coronary artery disease	2.6e-05	0.000379	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2—coronary artery disease	2.59e-05	0.000378	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	2.55e-05	0.000372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGT—coronary artery disease	2.55e-05	0.000371	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKMT1B—coronary artery disease	2.52e-05	0.000368	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CYBA—coronary artery disease	2.5e-05	0.000365	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB1—coronary artery disease	2.5e-05	0.000365	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DUSP6—coronary artery disease	2.49e-05	0.000363	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLAT—coronary artery disease	2.45e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	2.39e-05	0.000348	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	2.39e-05	0.000348	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL12—coronary artery disease	2.36e-05	0.000345	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BDKRB2—coronary artery disease	2.36e-05	0.000345	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—coronary artery disease	2.36e-05	0.000344	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2—coronary artery disease	2.35e-05	0.000343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6ST—coronary artery disease	2.34e-05	0.000342	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUNB—coronary artery disease	2.32e-05	0.000338	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	2.32e-05	0.000338	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	2.32e-05	0.000338	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLCB1—coronary artery disease	2.31e-05	0.000337	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR7—coronary artery disease	2.26e-05	0.00033	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	2.2e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	2.2e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	2.2e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	2.17e-05	0.000316	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	2.17e-05	0.000316	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGAV—coronary artery disease	2.16e-05	0.000314	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KNG1—coronary artery disease	2.15e-05	0.000313	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	2.14e-05	0.000313	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—coronary artery disease	2.14e-05	0.000312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CREB1—coronary artery disease	2.14e-05	0.000312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR1—coronary artery disease	2.14e-05	0.000312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—coronary artery disease	2.1e-05	0.000306	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	2.09e-05	0.000305	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6R—coronary artery disease	2.09e-05	0.000305	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL10—coronary artery disease	2.09e-05	0.000305	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLG—coronary artery disease	2.08e-05	0.000304	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKM—coronary artery disease	2.05e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPAP2B—coronary artery disease	2.05e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UQCRFS1—coronary artery disease	2.05e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB2—coronary artery disease	2.03e-05	0.000296	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	2.01e-05	0.000293	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCE—coronary artery disease	2e-05	0.000292	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—JAK2—coronary artery disease	2e-05	0.000292	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SOCS1—coronary artery disease	2e-05	0.000291	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—S100B—coronary artery disease	1.99e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SOCS3—coronary artery disease	1.97e-05	0.000288	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	1.97e-05	0.000287	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KITLG—coronary artery disease	1.95e-05	0.000284	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFBR2—coronary artery disease	1.95e-05	0.000284	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	1.93e-05	0.000282	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PDK4—coronary artery disease	1.91e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT4A1—coronary artery disease	1.91e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PYGM—coronary artery disease	1.91e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH6A1—coronary artery disease	1.91e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKMT2—coronary artery disease	1.91e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT5A—coronary artery disease	1.9e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP3—coronary artery disease	1.9e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—coronary artery disease	1.9e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOB—coronary artery disease	1.84e-05	0.000268	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—coronary artery disease	1.83e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—JAK2—coronary artery disease	1.82e-05	0.000265	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDN1—coronary artery disease	1.81e-05	0.000264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL5—coronary artery disease	1.8e-05	0.000262	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF1—coronary artery disease	1.77e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—coronary artery disease	1.77e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LPL—coronary artery disease	1.76e-05	0.000256	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RPS6KB1—coronary artery disease	1.74e-05	0.000254	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MEF2C—coronary artery disease	1.74e-05	0.000254	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PFKM—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMGCS2—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GK—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GYG1—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LDHA—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GATM—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGB3—coronary artery disease	1.7e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	1.66e-05	0.000243	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	1.66e-05	0.000243	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	1.66e-05	0.000243	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—coronary artery disease	1.66e-05	0.000242	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	1.65e-05	0.000241	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP2CA—coronary artery disease	1.65e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	1.64e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AK1—coronary artery disease	1.62e-05	0.000237	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCH1—coronary artery disease	1.62e-05	0.000237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCD—coronary artery disease	1.62e-05	0.000236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	1.61e-05	0.000234	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	1.59e-05	0.000231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—coronary artery disease	1.58e-05	0.000231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—C3—coronary artery disease	1.58e-05	0.000231	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCD1—coronary artery disease	1.56e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MDH2—coronary artery disease	1.56e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPAT—coronary artery disease	1.56e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGCG—coronary artery disease	1.56e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—coronary artery disease	1.51e-05	0.00022	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGT—coronary artery disease	1.5e-05	0.000219	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PGM1—coronary artery disease	1.5e-05	0.000219	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOE—coronary artery disease	1.47e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—coronary artery disease	1.47e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.47e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOA1—coronary artery disease	1.46e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.45e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKB—coronary artery disease	1.45e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PYGB—coronary artery disease	1.45e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—coronary artery disease	1.44e-05	0.00021	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK14—coronary artery disease	1.43e-05	0.000209	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—coronary artery disease	1.41e-05	0.000205	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—coronary artery disease	1.39e-05	0.000203	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2—coronary artery disease	1.39e-05	0.000203	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6ST—coronary artery disease	1.38e-05	0.000202	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NFKBIA—coronary artery disease	1.37e-05	0.0002	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DLAT—coronary artery disease	1.36e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM2—coronary artery disease	1.36e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLIN1—coronary artery disease	1.36e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COX5B—coronary artery disease	1.36e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PFKFB3—coronary artery disease	1.36e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIT—coronary artery disease	1.33e-05	0.000194	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.29e-05	0.000189	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT1E1—coronary artery disease	1.29e-05	0.000188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GSK3B—coronary artery disease	1.28e-05	0.000186	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—coronary artery disease	1.27e-05	0.000185	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREB1—coronary artery disease	1.27e-05	0.000185	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.25e-05	0.000183	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—coronary artery disease	1.24e-05	0.000181	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6R—coronary artery disease	1.23e-05	0.00018	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKR1B1—coronary artery disease	1.23e-05	0.00018	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HK2—coronary artery disease	1.23e-05	0.00018	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—coronary artery disease	1.22e-05	0.000178	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK1—coronary artery disease	1.21e-05	0.000177	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC27A1—coronary artery disease	1.18e-05	0.000172	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—coronary artery disease	1.16e-05	0.000169	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LCAT—coronary artery disease	1.16e-05	0.000169	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CPT1B—coronary artery disease	1.16e-05	0.000169	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—coronary artery disease	1.16e-05	0.000169	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA4—coronary artery disease	1.14e-05	0.000166	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—coronary artery disease	1.12e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.12e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—coronary artery disease	1.1e-05	0.000161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PDHA1—coronary artery disease	1.1e-05	0.00016	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCLM—coronary artery disease	1.1e-05	0.00016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAK2—coronary artery disease	1.07e-05	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.06e-05	0.000155	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TXNRD1—coronary artery disease	1.06e-05	0.000155	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP11B2—coronary artery disease	1.06e-05	0.000155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—coronary artery disease	1.05e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC22A3—coronary artery disease	1.05e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARNTL—coronary artery disease	1.03e-05	0.00015	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HADH—coronary artery disease	1.03e-05	0.00015	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.02e-05	0.000148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	9.91e-06	0.000144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—coronary artery disease	9.79e-06	0.000143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA2—coronary artery disease	9.78e-06	0.000143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	9.78e-06	0.000143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX2—coronary artery disease	9.78e-06	0.000143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HK1—coronary artery disease	9.66e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG5—coronary artery disease	9.66e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX4—coronary artery disease	9.66e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT1A1—coronary artery disease	9.66e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	9.65e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HADHA—coronary artery disease	9.55e-06	0.000139	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—coronary artery disease	9.46e-06	0.000138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA1—coronary artery disease	9.44e-06	0.000138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—coronary artery disease	9.37e-06	0.000137	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPA—coronary artery disease	9.33e-06	0.000136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—coronary artery disease	9.31e-06	0.000136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—coronary artery disease	9.12e-06	0.000133	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB3—coronary artery disease	9.04e-06	0.000132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA5—coronary artery disease	8.94e-06	0.00013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—coronary artery disease	8.86e-06	0.000129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—P4HB—coronary artery disease	8.77e-06	0.000128	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	8.69e-06	0.000127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	8.61e-06	0.000126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—coronary artery disease	8.59e-06	0.000125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	8.51e-06	0.000124	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	8.42e-06	0.000123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—VCAN—coronary artery disease	8.12e-06	0.000118	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDOA—coronary artery disease	8.05e-06	0.000117	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—coronary artery disease	7.95e-06	0.000116	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DCN—coronary artery disease	7.82e-06	0.000114	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH2—coronary artery disease	7.61e-06	0.000111	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.41e-06	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LIPC—coronary artery disease	7.41e-06	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HBA1—coronary artery disease	7.41e-06	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C19—coronary artery disease	7.41e-06	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	7.41e-06	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOC3—coronary artery disease	7.37e-06	0.000107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LDLR—coronary artery disease	7.32e-06	0.000107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.31e-06	0.000107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—coronary artery disease	7.3e-06	0.000106	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC9A1—coronary artery disease	7.23e-06	0.000105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—coronary artery disease	7.23e-06	0.000105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK1—coronary artery disease	7.16e-06	0.000104	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCLC—coronary artery disease	7.15e-06	0.000104	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CETP—coronary artery disease	7.15e-06	0.000104	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SDC1—coronary artery disease	7.07e-06	0.000103	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSMA6—coronary artery disease	6.68e-06	9.74e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSMB5—coronary artery disease	6.68e-06	9.74e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.67e-06	9.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CTGF—coronary artery disease	6.53e-06	9.51e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMGCR—coronary artery disease	6.47e-06	9.43e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GOT2—coronary artery disease	6.47e-06	9.43e-05	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—coronary artery disease	6.21e-06	9.06e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.95e-06	8.67e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.83e-06	8.51e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCA1—coronary artery disease	5.76e-06	8.4e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GOT1—coronary artery disease	5.58e-06	8.14e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GGT1—coronary artery disease	5.58e-06	8.14e-05	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—coronary artery disease	5.5e-06	8.02e-05	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—coronary artery disease	5.07e-06	7.4e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—coronary artery disease	5.01e-06	7.31e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.97e-06	7.24e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.95e-06	7.21e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—coronary artery disease	4.88e-06	7.11e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOB—coronary artery disease	4.74e-06	6.91e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.61e-06	6.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPL—coronary artery disease	4.52e-06	6.6e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX1—coronary artery disease	4.41e-06	6.43e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CD36—coronary artery disease	4.3e-06	6.27e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPP2CA—coronary artery disease	4.24e-06	6.19e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—coronary artery disease	4.07e-06	5.94e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AGT—coronary artery disease	3.87e-06	5.64e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOE—coronary artery disease	3.79e-06	5.53e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA1—coronary artery disease	3.75e-06	5.46e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.59e-06	5.23e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARG—coronary artery disease	3.3e-06	4.82e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—coronary artery disease	3.26e-06	4.75e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—coronary artery disease	2.97e-06	4.33e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—coronary artery disease	2.84e-06	4.14e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.6e-06	3.79e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.6e-06	2.33e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—coronary artery disease	1.31e-06	1.9e-05	CbGpPWpGaD
